Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study.

Alienor XhaardConstance XhaardMaud D'AveniHelene SalvatorMarie-Laure ChabiAna BerceanuTereza ComanYves BeguinYves ChalandonXavier PoireMichaël LoschiCatherine PaillardBenedicte BrunoPatrice CeballosJean-Hugues DalleKarin BilgerJacques-Olivier BayMarie RobinStephanie N'Guyen-QuocMarie-Therese Rubio

Published in: British journal of haematology (2021)

Keyphrases

stem cell transplantation
coronavirus disease
sars cov
high dose
study protocol
early onset
clinical trial
cross sectional
double blind
respiratory syndrome coronavirus
low dose
randomized controlled trial
drug induced
hematopoietic stem cell